Beyond RET: potential therapeutic approaches for advanced and metastatic medullary thyroid carcinoma
/in Dendritic Cells, International Publications, Thyroid Cancer /von 2009-07-01 / J. Intern. Med. 2009 Jul;266(1):99-113Vaccination with recombinant adenoviruses and dendritic cells expressing prostate-specific antigens is effective in eliciting CTL and suppresses tumor growth in the experimental prostate cancer
/in Dendritic Cells, International Publications, Malignant Melanoma, Prostate Cancer /von 2009-06-15 / Prostate 2009 Jun;69(9):938-48Monocyte-derived dendritic cells from HIV type 1-infected individuals show reduced ability to stimulate T cells and have altered production of interleukin (IL)-12 and IL-10
/in Dendritic Cells, HIV/AIDS, International Publications /von 2009-06-15 / J. Infect. Dis. 2009 Jun;199(12):1862-71Cellular immunotherapy for ovarian cancer
/in Dendritic Cells, International Publications, Ovarian Cancer /von 2009-06-01 / Expert Opin Biol Ther 2009 Jun;9(6):677-88Pilot trial of autologous dendritic cells loaded with tumor lysate(s) from allogeneic tumor cell lines in patients with metastatic medullary thyroid carcinoma
/in Dendritic Cells, International Publications, Thyroid Cancer /von 2009-06-01 / Oncol. Rep. 2009 Jun;21(6):1585-92[Dendritic cell-based immunotherapy for multiple myeloma — review]
/in Dendritic Cells, International Publications, Multiple Myeloma /von 2009-06-01 / Zhongguo Shi Yan Xue Ye Xue Za Zhi 2009 Jun;17(3):821-5Generation of a dendritic cell-based vaccine in chronic lymphocytic leukaemia using CliniMACS platform for large-scale production
/in Chronic Leukemia, Dendritic Cells, International Publications /von 2009-06-01 / Scand. J. Immunol. 2009 Jun;69(6):529-36Impact of surgery and chemotherapy on cellular immunity in pancreatic carcinoma patients in view of an integration of standard cancer treatment with immunotherapy
/in Dendritic Cells, International Publications, Pancreatic Cancer /von 2009-06-01 / Int. J. Oncol. 2009 Jun;34(6):1701-15Dendritic cell-based cancer immunotherapies
/in Dendritic Cells, International Publications /von 2009-05-29 / Arch. Immunol. Ther. Exp. (Warsz.) 2009 May-Jun;57(3):189-98IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de